NASDAQ · Drug Manufacturers - General

Amgen Inc (AMGN)

$466.01 +1.15%
Add alert See all overbought stocks →
71 Overbought Daily RSI (14) · 30 Oct 2026

Moving averages

SMA 200$367.00+26.98%

Company profile

Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. Focused on molecular biology and biochemistry, its goal is to provide a healthcare business based on recombinant DNA technology.

SectorHealthcare
IndustryDrug Manufacturers - General
Market cap$225.75B
P/E ratio26.1
EPS$16.00
Beta0.407
Dividend yield2.36%
52-week high$447.03
52-week low$280.23

ETFs holding AMGN

DIA 4.93% of the fund RSI 46 SCHD 3.97% of the fund RSI 75

Similar stocks in Drug Manufacturers - General

PFE Pfizer Inc RSI 67 LLY Lilly(Eli) & Company RSI 78 JNJ Johnson & Johnson RSI 60 BMY Bristol-Myers Squibb Company RSI 55 GILD Gilead Sciences Inc RSI 74 NVO Novo Nordisk RSI 54 MRK Merck & Co Inc RSI 57 ABBV Abbvie Inc RSI 73 GSK GSK Plc RSI 51 OGN Organon & Company RSI 68
30 days of PRO Unlimited free, no card

RSI alerts for AMGN

An email when AMGN closes below RSI 30 or above 70. Nothing else.

Add alert

Data last updated 13 October 2026 at 9:18 PM EDT